North America is Dominating Home-Use Insulin Delivery Devices Industry

The global home-use insulin delivery devices market is experiencing growth and is projected to reach USD 19,087.6 million in 2030, As per the report by market research company, P&S Intelligence. This growth can be credited to the growing occurrence of diabetes, the rising elderly populace, technological improvements, and snowballing exposure of the populace to vital risk factors, including a deskbound lifestyle, smoking, and obesity.

To learn more about this report: https://bit.ly/3UQ8Kdh

In the past few years, the insulin pens category generated the largest revenue share in the market, on the basis of type. This can be credited to the growing frequency of diabetes, mainly in Asia-Pacific nations, and technological growth in insulin delivery pens. Moreover, the medical subsidies offered in developed countries are enhancing market growth.

In the coming few years, the e-commerce category is projected to experience the fastest growth, on the basis of distribution channels in the home-use insulin delivery devices market. This can be credited to the development of e-pharmacies that provide suitability to customers. Moreover, the utilization of e-prescriptions in hospitals is boosting the growth of the category worldwide.

In recent years, North America dominated the market with the largest market share, mainly because of the rising occurrence of lifestyle-associated diseases, such as obesity and diabetes, growing healthcare expenditure, and increasing knowledge regarding diabetes management.

The utilization of insulin pens can be done in a much lower timespan in comparison to syringes with vials. Other benefits of insulin pens are better patient suitability and minimum risk of imprecise dosage.

Hence, the growing occurrence of diabetes, the rising elderly populace, technological improvements, and snowballing exposure of the populace to vital risk factors, including a deskbound lifestyle, smoking, and obesity are the major factors contributing to the growth of the home-use insulin delivery devices industry.